Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

The country is increasingly being recognized as a global middle power with a distinctive identity and a preference for inclusive multilateralism. On October 25-26, Vietnam collaborated with the United ...

Isola Della Musica Opera and Convention hall by Renzo Piano Building Workshop. Render. Image Courtesy of RPBW Isola Della Musica Opera and Convention hall by Renzo ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

HANOI, Oct 7 (Reuters) - Torrential rains triggered by Typhoon Matmo flooded parts of Hanoi on Tuesday, the latest in a series of deluges that have inundated the Vietnamese capital over the past month ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Air pollution in Hanoi is causing widespread health problems and productivity losses. While the government is moving to phase out petrol vehicles and curb urban emissions, much of the city’s pollution ...

The city vibe is… cultural, historical and traditional. Hanoi is Vietnam’s capital, a sophisticated, thousand-year-old city whose heartbeat emanates from the Old Quarter. Here, 19th-century ...

Photos of the Vietnamese capital, home to almost 9 million people, show the environmental cost of the Southeast Asian nation’s explosive growth. HANOI, Vietnam — Hanoi has no horizon. Blocky apartment ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...